IBRX
Price
$2.72
Change
+$0.08 (+3.03%)
Updated
Jul 3 closing price
Capitalization
2.4B
30 days until earnings call
ITRM
Price
$0.96
Change
-$0.01 (-1.03%)
Updated
Jul 3 closing price
Capitalization
38.56M
32 days until earnings call
Interact to see
Advertisement

IBRX vs ITRM

Header iconIBRX vs ITRM Comparison
Open Charts IBRX vs ITRMBanner chart's image
ImmunityBio
Price$2.72
Change+$0.08 (+3.03%)
Volume$3.28M
Capitalization2.4B
Iterum Therapeutics
Price$0.96
Change-$0.01 (-1.03%)
Volume$491.96K
Capitalization38.56M
IBRX vs ITRM Comparison Chart in %
Loading...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IBRX vs. ITRM commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBRX is a Hold and ITRM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (IBRX: $2.72 vs. ITRM: $0.96)
Brand notoriety: IBRX and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBRX: 33% vs. ITRM: 90%
Market capitalization -- IBRX: $2.4B vs. ITRM: $38.56M
IBRX [@Biotechnology] is valued at $2.4B. ITRM’s [@Biotechnology] market capitalization is $38.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • IBRX’s FA Score: 1 green, 4 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, both IBRX and ITRM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBRX’s TA Score shows that 4 TA indicator(s) are bullish while ITRM’s TA Score has 3 bullish TA indicator(s).

  • IBRX’s TA Score: 4 bullish, 5 bearish.
  • ITRM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than ITRM.

Price Growth

IBRX (@Biotechnology) experienced а -2.51% price change this week, while ITRM (@Biotechnology) price change was -5.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.51%. For the same industry, the average monthly price growth was +14.00%, and the average quarterly price growth was -0.49%.

Reported Earning Dates

IBRX is expected to report earnings on Aug 06, 2025.

ITRM is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+5.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.4B) has a higher market cap than ITRM($38.6M). IBRX YTD gains are higher at: 6.250 vs. ITRM (-45.542). ITRM has higher annual earnings (EBITDA): -19.12M vs. IBRX (-264M). IBRX has more cash in the bank: 61.6M vs. ITRM (12.7M). ITRM has less debt than IBRX: ITRM (32M) vs IBRX (526M). IBRX has higher revenues than ITRM: IBRX (31.2M) vs ITRM (0).
IBRXITRMIBRX / ITRM
Capitalization2.4B38.6M6,220%
EBITDA-264M-19.12M1,381%
Gain YTD6.250-45.542-14%
P/E RatioN/AN/A-
Revenue31.2M0-
Total Cash61.6M12.7M485%
Total Debt526M32M1,644%
FUNDAMENTALS RATINGS
IBRX vs ITRM: Fundamental Ratings
IBRX
ITRM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (4) in the Biotechnology industry is significantly better than the same rating for ITRM (88). This means that IBRX’s stock grew significantly faster than ITRM’s over the last 12 months.

IBRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ITRM (100). This means that IBRX’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's SMR Rating (99) in the Biotechnology industry is in the same range as IBRX (100). This means that ITRM’s stock grew similarly to IBRX’s over the last 12 months.

IBRX's Price Growth Rating (63) in the Biotechnology industry is in the same range as ITRM (64). This means that IBRX’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for IBRX (100). This means that ITRM’s stock grew significantly faster than IBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IBRXITRM
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 28 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHCLX11.730.13
+1.12%
AB Discovery Growth A
JDVVX24.420.20
+0.83%
JHancock Disciplined Value R5
HGXSX17.080.14
+0.83%
Hartford Global Impact R4
AHSZX19.160.09
+0.47%
Alger Health Sciences Z
CIESX27.14-0.06
-0.22%
Calvert International Equity R6

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with RXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
+3.03%
RXRX - IBRX
42%
Loosely correlated
+1.15%
CLRB - IBRX
41%
Loosely correlated
N/A
QTTB - IBRX
38%
Loosely correlated
N/A
NRIX - IBRX
37%
Loosely correlated
+2.33%
ARCT - IBRX
37%
Loosely correlated
+1.17%
More

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with ACRS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-0.42%
ACRS - ITRM
34%
Loosely correlated
-0.69%
TARA - ITRM
34%
Loosely correlated
+3.96%
TRDA - ITRM
27%
Poorly correlated
N/A
IBRX - ITRM
26%
Poorly correlated
+3.03%
LGVN - ITRM
26%
Poorly correlated
+0.77%
More